EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+3.34%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.11B
AUM Growth
+$1.11B
(+5.8%)
Cap. Flow
+$47.4M
Cap. Flow
% of AUM
4.26%
Top 10 Holdings %
Top 10 Hldgs %
62.54%
Holding
76
New
10
Increased
33
Reduced
12
Closed
14
Top Buys
| 1 |
Community Health Systems
CYH
|
$34.7M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$30.4M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$17M |
| 4 |
AMED
Amedisys
AMED
|
$16.5M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$13.1M |
Top Sells
| 1 |
Sanofi
SNY
|
$77.7M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$26.8M |
| 3 |
Envista
NVST
|
$21.6M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$17.9M |
| 5 |
Haleon
HLN
|
$15.1M |
Sector Composition
| 1 | Healthcare | 98.05% |
| 2 | Financials | 1.22% |
| 3 | Communication Services | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $157M | 10.92% | 2,819,770 +133,811 | +5% | +$7.43M |
|
2
GSK
GSK
$79.9B
| $134M | 9.34% | 3,731,499 +241,042 | +7% | +$8.65M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $89.4M | 6.23% | 819,124 -245,322 | -23% | -$26.8M |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $54.8M | 3.82% | 6,194,572 +1,481,975 | +31% | +$13.1M |
|
5
United Therapeutics
UTHR
$13.8B
| $49.7M | 3.47% | 222,107 -10,680 | -5% | -$2.39M |
|
6
Syndax Pharmaceuticals
SNDX
$1.41B
| $46.7M | 3.25% | 2,209,057 +588,344 | +36% | +$12.4M |
|
|
7
Community Health Systems
CYH
$387M
| $44.5M | 3.1% | 9,082,305 +7,080,311 | +354% | +$34.7M |
|
8
Biogen
BIIB
$19.4B
| $42.8M | 2.98% | 153,774 +16,426 | +12% | +$4.57M |
|
9
Illumina
ILMN
$15.8B
| $39.7M | 2.77% | 170,537 +30,470 | +22% | +$7.09M |
|
|
10
BioCryst Pharmaceuticals
BCRX
$1.74B
| $37.7M | 2.63% | 4,520,724 +3,640,237 | +413% | +$30.4M |
|
|
CTLT
11
DELISTED
CATALENT, INC.
CTLT
| $37.7M | 2.63% | 573,609 -118,068 | -17% | -$7.76M |
|
12
Danaher
DHR
$147B
| $37.5M | 2.62% | 148,685 -13,886 | -9% | -$3.5M |
|
13
Celldex Therapeutics
CLDX
$1.47B
| $24.8M | 1.73% | 689,676 +130,902 | +23% | +$4.71M |
|
|
AMRN
14
Amarin Corp
AMRN
$311M
| $21.9M | 1.53% | 14,612,757 +11,328,643 | +345% | +$17M |
|
15
Centene
CNC
$14.3B
| $18.2M | 1.27% | 288,426 +73,865 | +34% | +$4.67M |
|
|
AMED
16
DELISTED
Amedisys
AMED
| $16.5M | 1.15% | +224,263 | New | +$16.5M |
|
17
Icon
ICLR
$13.8B
| $16.4M | 1.14% | 76,788 +10,095 | +15% | +$2.16M |
|
18
Avantor
AVTR
$9.18B
| $15.2M | 1.06% | 717,614 +117,414 | +20% | +$2.48M |
|
19
Seres Therapeutics
MCRB
$166M
| $14.4M | 1% | 2,536,665 +335,666 | +15% | +$1.9M |
|
20
Bio-Techne
TECH
$8.5B
| $14M | 0.98% | 188,659 +172,024 | +1,034% | +$12.8M |
|
21
Vera Therapeutics
VERA
$1.38B
| $13.9M | 0.97% | 1,788,529 +1,377,221 | +335% | +$10.7M |
|
|
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.8M | 0.83% | +218,726 | New | +$11.8M |
|
23
eHealth
EHTH
$118M
| $11.6M | 0.81% | +1,234,283 | New | +$11.6M |
|
24
Guardant Health
GH
$8.41B
| $11.3M | 0.79% | 483,098 +336,969 | +231% | +$7.9M |
|
25
Vaxcyte
PCVX
$4B
| $11.2M | 0.78% | 299,050 +120,597 | +68% | +$4.52M |
|